Episode 60
Biotech Hangout
00:00
The FDA's Tough on Noninvasive Diagnostic Tests for NASH
The FDA is definitely very tough on noninvasive diagnostic tests for NASH. What is the right way to look at noninvasive? And that's really a question long term for everybody from a caromagical. So I would say this data looks pretty good, but again, it's just 12 week data, you know, looking at MRIs. and I think to really feel like super comfortable about this, we need to see longer term and especially some of that biopsy data in the future.
Transcript
Play full episode
